Format

Send to

Choose Destination
Mol Cell Endocrinol. 2012 Feb 26;349(2):248-54. doi: 10.1016/j.mce.2011.10.032. Epub 2011 Nov 18.

Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver.

Author information

1
Department of Internal Medicine I, Regensburg University Hospital, Regensburg D-93042, Germany.

Erratum in

  • Mol Cell Endocrinol. 2012 May 15;355(1):190.

Abstract

Chemokine-like receptor 1 (CMKLR1) ligands chemerin and resolvin E1 are suggested to have a role in non-alcoholic fatty liver disease (NAFLD). Here, expression of CMKLR1 in liver cells and NAFLD was studied. CMKLR1 was detected in primary human hepatocytes (PHH), Kupffer cells, bile-duct cells and hepatic stellate cells. In human and rodent fatty liver and in fibrotic liver of mice fed a methionine-choline deficient diet CMKLR1 was reduced. Hepatocytes are the major cells in the liver and effects of adipokines, cytokines and lipids on CMKLR1 in PHH were analyzed. Increased cellular triglyceride or cholesterol content, lipopolysaccharide, IL-6, TNF and leptin did not influence CMKLR1 levels in PHH whereas profibrotic TGFβ tended to reduce CMKLR1. Adiponectin strongly upregulated CMKLR1 mRNA and protein in PHH and hepatic CMKLR1 when injected into wild type mice. Further, CMKLR1 was suppressed in the liver of adiponectin deficient mice. These data indicate that low CMKLR1 in NAFLD may partly result from reduced adiponectin activity.

PMID:
22118966
PMCID:
PMC3670424
DOI:
10.1016/j.mce.2011.10.032
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center